Saturday, September 6


09:00 – 10:35

PLENARY SESSION 7: MANAGEMENT OF THE RELAPSED PATIENT

ModeratorJesús F. San-Miguel
09:00 - 09:20How should I treat relapsed patients (with approved drugs)?
Michel Delforge
09:20 - 09:40Bispecific and ADC : when and how?
Paula Rodríguez -Otero
09:40 - 10:00CAR-T cells and other adoptive therapies: when and how?
Hermann Einsele
10:00 - 10:20Are new pathways to be targeted in Myeloma?
Enrique Ocio
10:20 - 10:35Experts' discussion around 5 burning topics:

  1. 1. Biological relapse versus aggressive relapse

  2. 2. Triplet versus doublets: is it cost-effective?

  3. 3. Is CAR-T the future? alone or combined with anti-MM drugs?

  4. 4. Bispecific antibodies or CAR-T

  5. 5. Industry or academia
Discussants: Dr. San-Miguel, Dr. Delforge, Dr. Rodríguez-Otero, Dr. Einsele, Dr. Ocio, Dr. Kastritis, Dr. Yong

10:35 – 10:45

Break

10:45 – 12:00

PLENARY SESSION 8: HOW I TREAT OTHER MALIGNANT GAMMOPATHIES

ModeratorJesús F. San-Miguel
10:45 - 11:05Amyloidosis: what should I know?
Ramón Lecumberri
11:05 - 11:25Waldenstrom macroglobulinemia: what should I know?
Efstathios Kastritis
11:25 - 11:45EHA-2025 Guidelines: how can help me in my daily practice
Evangelos Terpos
11:45 - 12:00Questions & discussion

12:00 – 12:15

CLOSING REMARKS

Jesús F. San-Miguel